CollPlant raises $3.7M to fund laser-based supercomputing push
What's the deal? CollPlant BiotechnologiesDealroom has a profile for this one. Try Dealroom → (Nasdaq: CLGN) has entered definitive agreements for a $3.7 million private placement, selling 989,301 ordinary shares and warrants to buy up to 1,483,952 more. The Rehovot, Israel-based company priced the deal at $3.74 per share and accompanying warrants, with closing expected around October 14, 2026.
Where's the money going? CollPlant will use net proceeds primarily to accelerate research and development at its subsidiary LightSolver, which is building a laser-based supercomputing architecture and its Laser Processing Unit (LPU) technology. The rest is earmarked for working capital and general corporate purposes.
Who's backing it? The round is made up primarily of CollPlant's existing investors, which the company says reflects confidence in its shift toward deep-tech photonic computing. H.C. Wainwright & Co.Dealroom has a profile for this one. Try Dealroom → and Rodman & Renshaw LLCDealroom has a profile for this one. Try Dealroom → acted as exclusive joint placement agents.
What's the endgame? CollPlant operates at the intersection of photonic computing and biotechnology. Through LightSolver, it aims to build all-optical computing systems targeting bottlenecks in artificial intelligence, aerospace, financial engineering, and high-performance computing, while remaining a player in regenerative medicine via plant-derived recombinant human collagen.
The signal: At $3.7 million, this is a small raise — landing in roughly the bottom fifth of comparable rounds by size. For CollPlant, the modest cheque funds a notable pivot, channelling capital from a collagen-focused biotech into an ambitious laser-computing bet.
Read more: pr.sandyjournal.com
Image credit: jurvetson
